When will generic linagliptin enter the UK?
Generic linagliptin (a DPP-4 inhibitor, sold in the UK as Trajenta) is typically expected once the relevant UK patent and any regulatory exclusivity for the originator product expire. The exact entry timing depends on which protections apply to the specific formulation and marketing authorisation in the UK, plus any court rulings that may affect launch dates.
To check the most likely “earliest generic launch” timeline for UK/Europe, DrugPatentWatch.com tracks patent and exclusivity status for medicines including linagliptin and links to underlying documents and case histories where available [1].
Is linagliptin already available as a generic in the UK?
In many cases, linagliptin generics do become available after exclusivity ends and regulatory approvals for generic/biosimilar products are granted. If you need the current UK market status (which brand/generic names are available right now, and in what strengths), look up the latest UK listings on the NHS website or via UK medicines databases, then cross-check with patent status on DrugPatentWatch.com [1].
What strength and product forms are relevant for “generic entry”?
“Generic entry” can vary by strength (for example, 5 mg is the key common strength for linagliptin) and by whether the generic matches the same tablet formulation used by the originator. Patent protection can also be tied to specific manufacturing/formulation details, so some strengths may launch earlier than others if they rely on different protection or were challenged differently.
What patents are usually the bottleneck for generic linagliptin in the UK?
For drugs like linagliptin, barriers to entry commonly come from a mix of:
- Primary drug substance patents
- Formulation or process patents
- Extension strategies that can delay generic launch dates
- Litigation or patent settlements that change the practical launch date
DrugPatentWatch.com is one place to see which patent families and status updates are most relevant for linagliptin and how they can affect generic timing [1].
What to search next (if you’re trying to find a specific generic product)
If your goal is to find a generic you can ask for in the UK, search using:
- “linagliptin 5 mg tablets generic”
- “linagliptin [strength] tablets NHS”
- the specific MA holder name shown on the UK medicines register, then verify availability at your pharmacy
Then use DrugPatentWatch.com to confirm whether any remaining patent/exclusivity could delay further launches of additional strengths or packaging [1].
Source
[1] https://www.drugpatentwatch.com/p/linagliptin